Principal Financial Group
DFTX

Principal Financial Group’s Definium Therapeutics DFTX Stock Holding History

Principal Financial Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$468K Buy
+9,952
New +$246K ﹤0.01% 2008
2022
Q2 		– Sell
-3,899
Closed -$65K – 2600
2022
Q1 		$65K Sell
3,899
-47
-1% -$815 ﹤0.01% 2473
2021
Q4 		$82K Sell
3,946
-921
-19% -$29.4K ﹤0.01% 2455
2021
Q3 		$170K Buy
4,867
+1,434
+42% +$62K ﹤0.01% 2451
2021
Q2 		$178K Buy
+3,433
New +$180K ﹤0.01% 2485

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Principal Financial Group's DFTX Position: Q2 2026 in Review

Principal Financial Group opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 9,952 shares worth $468K. The stake represents ﹤0.01% of the portfolio and ranks #2008 among its holdings. This is a return to the name: Principal Financial Group previously reported a position in DFTX as recently as Q1 2022.

Principal Financial Group first reported a position in DFTX in Q2 2021 and has held it in 5 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Principal Financial Group held 9,952 shares of Definium Therapeutics worth $468K as of Q2 2026.
  • Definium Therapeutics was a new Principal Financial Group position in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #2008 holding.
  • Principal Financial Group first reported a position in Definium Therapeutics in Q2 2021 and has held it in 5 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.